Mesh : Autoantibodies / biosynthesis Blood Coagulation Disorders, Inherited / drug therapy Blood Coagulation Factors / therapeutic use Blood-Borne Pathogens Coagulants / adverse effects immunology therapeutic use Evidence-Based Medicine / methods Hemophilia A / drug therapy Hemophilia B / drug therapy Humans Male Recombinant Proteins / therapeutic use Thrombosis / chemically induced Virus Inactivation

来  源:   DOI:10.1111/j.1365-2516.2008.01695.x

Abstract:
Evidence-based guidelines are presented on the selection and use of therapeutic products to treat haemophilia and other hereditary bleeding disorders. They include details of therapeutic products available in the UK and they update and replace previous United Kingdom Haemophilia Centre Doctors\' Organisation guidelines.
摘要:
提供了有关选择和使用治疗血友病和其他遗传性出血性疾病的治疗产品的循证指南。它们包括在英国提供的治疗产品的细节,并更新和取代以前的英国血友病中心医生组织指南。
公众号